We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months

News   Sep 25, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months
 
 
Advertisement
 

RELATED ARTICLES

New Compound Traps the Malaria Parasite Inside Cells

News

Researchers have designed a drug-like compound that effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential malaria treatment.

READ MORE

Researchers Decode the "Language" of Immune Cells

News

Scientists have identified six "words" that specific immune cells use to call up immune defense genes. This is an important step toward understanding the language the body uses to marshal responses to threats.

READ MORE

New Molecule Could Enable Use of THC To Fight Pain Without the Side Effects

News

Researchers have developed a peptide that, in mice, allowed the main component of Cannabis sativa to fight chronic pain without impacting memory and other cognitive functions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE